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Foxp3 is a transcript factor for regulatory T cell development. 
Interestingly,  Foxp3-expressing cells were identified in B 
cells, especially in CD19(＋)CD5(＋) B cells, while those 
were not examined in CD19(＋)CD5(−) B cells. Foxp3- 
expressing CD5(＋) B cells in this study were identified in 
human PBMCs and were found to consist of 8.5±3.5% of 
CD19(＋)CD5(＋) B cells. CD19(＋)CD5(＋)Foxp3(＋) B 
cells showed spontaneous apoptosis. Rare CD19(＋)CD5(＋) 
Foxp3(＋) regulatory B cell (Breg) population was unveiled in 
human peripheral blood mononuclear cells and suggested as 
possible regulatory B cells (Breg) as regulatory T cells 
(Treg). The immunologic and the clinical relevant of Breg 
needs to be further investigated.
[Immune Network 2010;10(6):247-249]
CD5(＋)  B  c e l l s  c o n s t i t u t e  a  s u b s e t  o f  B  c e l l s  a n d  a  s u b -
population of CD5(＋) B cells produced IL-10 and suggested 
as a regulatory B cell, ‘Br1’ (1,2). The disease relationship 
of IL-10-producing regulatory B cells, especially in the human 
food allergy of atopic dermatitis, was described in a previous 
report of ours (3,4). Transcription factor Foxp3 is a transcript 
factor that controls the development of regulatory T cells and 
is involved in the negative regulation of immune responses 
(5).  In  this  study,  CD19(＋)CD5(＋)Foxp3(＋)  regulatory  B 
cells (Breg) were demonstrated and characterized for the first 
time.
    Venous  blood  was  obtained  from  six  normal  subjects 
(mean  age=15.3±3.5  years,  M：F=3：3 )  w h o  v i s i t e d  t h e  
Department of Allergy and Clinical Immunology at the Seoul 
Allergy Clinic for heath examination between March and June 
2010; subjects had no specific disease. Signed consent forms 
were  obtained  from  either  the  patient  or  the  parent.  The 
s t u d y  w a s  a p p r o v e d  b y  t h e  I n s t i t u t i o n a l  R e v i e w  B o a r d  o f  
Chungnam  University  Hospital,  Daejeon,  Korea.
    Peripheral blood mononuclear cells (PBMCs) were isolated 
from  venous  blood  using  density-gradient  separation  and 
F i c o l l - H y p a q u e  ( B i o m e d i c a l s ,  A u r o r a ,  O H ,  U S A ) .  P B M C s  
were resuspended at 1×10
6 cells/ml in α-minimum essential 
medium (α-MEM; Irvine Scientific, Santa Ana, CA). CD19(＋) 
CD5(＋)Foxp3(＋) regulatory B cells (Breg) were examined 
using  fluorescence-labelled  anti-CD5,  anti-CD19,  and  an-
ti-Foxp3 antibodies. Apoptotic characteristics were evaluated 
using  fluorescence-labelled  Annexin  V.
    The cells to be stained were prepared at a concentration 
of 1×10
6 cells in 100μl of FACS staining buffer (eBioscience) 
in an eppendorf tube. Cells were stained with specific mono-
clonal  antibodies  including  allophycocyanin  (APC)-labelled 
anti-CD19 (eBioscience) antibody, phycoerythrin-Cy7 (PE-Cy7)- 
labelled anti-CD5 antibody (eBioscience) and/or FITC-labelled 
Annexin  V  (eBioscience)  for  surface  staining.  at  a  concen-
tration  of  1μg/ml.  After  one  hour  incubation  in  the  dark, Human Foxp3(＋) Regulatory B Cell (Breg)
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Figure 2. Characteristics of Foxp3-expressing cells in CD19(＋) B cells.
(A) Foxp3(＋) cell % in CD19(＋)CD5(＋) and CD19(＋)CD5(−) B cell 
subpopulations. (B) Apoptotic characteristics of CD19(＋)CD5(＋) 
Foxp3(＋) regulatory B cells (Breg) in a representative case. PBMCs 
were gated by the expression of CD19 and CD5. Each set of CD19
(＋)CD5(−) B cells and CD19(＋)CD5(＋) B cells, CD19(−)CD5(−) 
cell was analyzed for Foxp3 expression and annexin V staining.
Figure 1. Foxp3 expression in only CD5(＋) cells in B cells. B cells 
were subgated by the surface CD19 expression and analyzed by the
expression of CD5 and Foxp3.
cells were washed with FACS staining buffer three times. The 
cells  were  then  resuspended  in  100μl  of  permeabilisa-
tion/fixation  buffer  (ebioscience)  just  before  intracellular 
staining.  After  finishing  the  cell  surface  staining  and  fix-
ation/permeabilization, the cells were stained with a phycoer-
ythrin (PE)-labelled anti-Foxp3 monoclonal antibody (eBioscience) 
in a dark room for 30 minutes at 4
oC. After cell surface and 
intracellular  staining,  cells  were  resuspended  in  500  ul  of 
FACS  staining  buffer.  The  stained  cells  were  acquired  with Human Foxp3(＋) Regulatory B Cell (Breg)
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a FACSCaliber (BD Biosciences, Milpitas, CA, USA), and the 
data were analysed with CellQuest software (BD Biosciences).
    CD19(＋)  B  cells  expressed  the  intracellular  Foxp3 t r a n -
s c r i p t  f a c t o r ,  e s p e c i a l l y  o n l y  i n  a  C D 5 ( ＋)  B  cell  sub-
population  in  B  cells  (Fig.  1).  Foxp3 e x p r e s s i o n  w a s  e x -
clusively  identified  in  the  CD5(＋)  population  of  CD19(＋) 
B cells and Foxp3(＋) cells fraction was 8.5±3.5% in CD19
(＋)CD5(＋) B cells and 0.1±0.1 % in CD19(＋)CD5(−) B 
cells (Fig. 2A). In the representative case, the apoptotic fre-
quency of CD19(＋)CD5(＋) Foxp3(＋) B cells was 63.44% 
(9.37%/(9.37＋5.40%)) (Fig. 2B) and CD19(＋)CD5(＋) B cells 
showed  highly  apoptotic  characteristics  using  Annexin  V. 
    Forkhead/winged-helix  protein,  Foxp3,  i s  a  t r a n s c r i p t i o n  
factor  that  controls  the  development  of  regulatory  T  cells 
(Treg) and has been reported to be expressed only in CD4
(＋)  T  cells  and  not  in  CD19(＋)  B  cells  or  in  CD8(＋)  T 
cells of mice (5). These CD4(＋)Foxp3(＋) T cells are well 
k n o w n  a s  T r e g ;  t h e y  p a r t i c i p a t e  i n  n e g a t i v e  i m m u n e  r e g u -
lations (5). IL-10-producing CD5(＋) B cells (Br1) also pre-
vented and reversed allergic airway inflammation via Foxp3
(＋) T regulatory cells in a murine model (6). In this study, 
Foxp3-expressing CD5(＋) B cells, as another subpopulation 
of CD5(＋) B cell, were identified, in addition to IL-10-pro-
ducing regulatory B cells (Br1) and TGF-β-producing regu-
l a t o r y  B  c e l l s  ( B r 3 )  ( 7 ) .  M o r e o v e r ,  C D 1 9 ( ＋)CD5(＋)Foxp3
(＋) B cells showed high spontaneous apoptotic frequency. 
(Fig.  2B).  In  mice,  14%  of  B  cells  underwent  spontaneous 
apoptosis (8). CD19(＋)CD5 (＋)Foxp3(＋) B  cells  showed 
considerable spontaneous apoptosis as compared to other cell 
populations, especially to populations of B cells in human.
    CD19(＋)CD5(＋)Foxp3(＋)  r e g u l a t o r y  B  c e l l s  ( B r e g )  
seemed to be another kind of regulatory B cells. It may be 
time to arrange systemically the nomenclature for regulatory 
B cell subsets; as IL-10-producing regulatory B cells as Br1 
(4)  like  Tr1  of  IL-10-producing  T  cells  (5)  and  as  TGF-β
-producing regulatory B cells as Br3 (7) like Th3 of TGF-β
-producing T cells (9). In addition, it has been suggested that 
CD19(＋) CD5(＋)Foxp3(＋) B cells be defined as a Breg like 
Treg  of  T  helper  cells  expressing  transcript  factor  Foxp3.
    Conclusively,  CD19(＋)CD5(＋)Foxp3(＋)  regulatory  B 
cells were identified for the first time in this study. CD19(＋) 
CD5(＋)Foxp3(＋)B  cells  were  suggested  as  possible  regu-
latory B cells (Breg), a subpopulation of CD5(＋) B1 cell, and 
were found to have highly apoptotic characteristics. The ex-
act  role  and  immunologic  significance  of  CD19(＋)CD5(＋) 
Foxp3(＋) regulatory B cells need to be further investigated.
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